PMID: 3763036Sep 29, 1986Paper

Brucellosis therapy

Minerva medica
F Di Nola, M L Soranzo

Abstract

The reasons for the use of a fat-soluble drug with an in vitro activity against Brucella spp in the treatment of brucellosis are presented. After a review of the literature a series of 222 cases subjected to various treatments is presented and it is concluded that an RMV-minocycline association offers the best antibacterial and kinetic characteristics.

Related Concepts

Related Feeds

Brucellosis

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.

Brucellosis (ASM)

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.

Related Papers

Journal of Veterinary Emergency and Critical Care
Alberto L FernandezKristin Engebretsen
Current Opinion in Pulmonary Medicine
Asim Maqbool, Virginia A Stallings
The American Journal of Clinical Nutrition
Henar OrtegaMiguel Angel Lasunción
Acta Neurologica Scandinavica. Supplementum
Ø TorkildsenT Holmøy
Molecular Nutrition & Food Research
David P R Muller
© 2021 Meta ULC. All rights reserved